BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2890019)

  • 1. Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.
    Coghlan JG; Gilligan D; Humphries H; McKenna D; Dooley C; Sweeney E; Keane C; O'Morain C
    Lancet; 1987 Nov; 2(8568):1109-11. PubMed ID: 2890019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
    Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
    Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication.
    Borody TJ; Cole P; Noonan S; Morgan A; Lenne J; Hyland L; Brandl S; Borody EG; George LL
    Med J Aust; 1989 Oct; 151(8):431-5. PubMed ID: 2687668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cure of duodenal ulcer after eradication of Helicobacter pylori.
    George LL; Borody TJ; Andrews P; Devine M; Moore-Jones D; Walton M; Brandl S
    Med J Aust; 1990 Aug; 153(3):145-9. PubMed ID: 1974027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.
    Hui WM; Lam SK; Ho J; Ng I; Lau WY; Branicki FJ; Lai CL; Lok AS; Ng MM; Fok J
    Am J Med; 1989 Jun; 86(6A):60-5. PubMed ID: 2660558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonist.
    Ho J; Hui WM; Ng I; Lam SK
    Aliment Pharmacol Ther; 1989 Jun; 3(3):315-20. PubMed ID: 2577695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
    Goodwin CS; Marshall BJ; Blincow ED; Wilson DH; Blackbourn S; Phillips M
    J Clin Pathol; 1988 Feb; 41(2):207-10. PubMed ID: 3280609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
    Rauws EA; Tytgat GN
    Lancet; 1990 May; 335(8700):1233-5. PubMed ID: 1971318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.
    Miller JP; Faragher EB
    Scand J Gastroenterol Suppl; 1989; 160():39-45. PubMed ID: 2573145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Campylobacter pylori in patients with chronic gastritis and gastric and duodenal peptic ulcer].
    Kolarski V; Tsenova V; Shopova K; Vasileva E; Petrova D
    Vutr Boles; 1989; 28(2):58-62. PubMed ID: 2763525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
    Sobhani I; Chastang C; De Korwin JD; Lamouliatte H; Mégraud F; Guerre J; Elouaer-Blanc L
    Gastroenterol Clin Biol; 1995 Mar; 19(3):252-8. PubMed ID: 7781936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duodenal ulcer disease: what role does Campylobacter pylori play?
    Smith AC
    Scand J Gastroenterol Suppl; 1989; 160():14-8. PubMed ID: 2683020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.
    Lambert JR; McLean AJ
    Med J Aust; 1989 Aug; 151(3):120-2. PubMed ID: 2755371
    [No Abstract]   [Full Text] [Related]  

  • 16. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism.
    Levi S; Beardshall K; Swift I; Foulkes W; Playford R; Ghosh P; Calam J
    BMJ; 1989 Dec; 299(6714):1504-5. PubMed ID: 2514864
    [No Abstract]   [Full Text] [Related]  

  • 17. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers.
    Wang WM; Chen CY; Jan CM; Chen LT; Perng DS; Lin SR; Liu CS
    J Formos Med Assoc; 1993 Aug; 92(8):721-4. PubMed ID: 7904847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Campylobacter pylori and treatment of duodenal ulcer].
    Zelenková J; Toman R; Bielaszewská M; Hanika J; Zeman V
    Vnitr Lek; 1990 Jun; 36(6):573-9. PubMed ID: 2219764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campylobacter pylori as a pathogenetic factor in duodenal ulcer: the case for.
    Graham DY
    Scand J Gastroenterol Suppl; 1989; 160():46-52. PubMed ID: 2814348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of Campylobacter pylori and recurrence of duodenal ulcer. A six-month follow-up study.
    Mouzas IA; Kalantzis N; Gabriel P; Kallimanis G; Papantoniou P; Mavrogiannis H
    Acta Gastroenterol Latinoam; 1990; 20(3):159-61. PubMed ID: 2095099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.